Experimental Alzheimer’s drug delivers promising Phase 2 trial results

Although yet to be published in a peer-reviewed journal, pharmaceutical company Eli Lilly has announced promising results from one of its Phase 2 human trials testing an experimental Alzheimer’s disease drug designed to slow cognitive decline.
Category: Science
Tags: Alzheimer’s Disease, Dementia, Drugs, Protein, Neuroscience, Brain
Continue reading Experimental Alzheimer’s drug delivers promising Phase 2 trial results

